A sharp first-half reset
Judges Scientific, the owner of specialist scientific instrument businesses, reported on 23 September 2026 that first-half profit had fallen far faster than sales. The key question is how a group that kept its full-year guidance can also describe its latest dividend cover as not sustainable.
The numbers
For the six months to 30 June 2026, revenue was £55.7m, down 21% from £70.2m. Adjusted operating profit fell 66% to £4.8m, from £14.3m, and adjusted pre-tax profit fell 75% to £3.2m. Adjusted basic earnings per share were 39.0p, against 141.4p a year earlier. On a statutory basis the group made a pre-tax loss of £1.7m, compared with a £6.6m profit, with £4.9m of adjusting items, mostly amortisation of acquired intangibles. Cash generated from operations was £4.3m, against £12.3m.
Materials Sciences revenue fell to £25.1m from £35.7m, and Vacuum to £30.6m from £34.5m.
Causes
Management attributed roughly eight percentage points of the revenue decline to the absence of a Geotek coring expedition and about thirteen points, net, to US federal research funding uncertainty, offshore wind delays and Chinese delays over research tax exemptions. Order intake fell 12% in the half, with the first quarter down 18% and the second closer to the prior year. China and Hong Kong orders dropped 47%. The order book stood at 17.3 weeks, against 17.4 weeks a year earlier. The group said order intake since the period end is only about 1% below last year.
Balance sheet and dividend
Adjusted net debt rose to £45.3m from £42.6m at the end of 2025, and gearing, as the company defines it, increased to 2.1 times from 1.5 times. Bank debt of £58.6m was drawn against a £90m revolving facility, and after the period end the facilities were extended to 1 July 2030 on unchanged covenants. The board declared an interim dividend of 36.0p, up from 32.7p, which is covered 1.1 times by adjusted earnings against 4.3 times a year earlier. The company says that level of cover is not sustainable. Payment is due on 6 November 2026.
Outlook and context
Management left 2026 guidance unchanged, saying adjusted earnings per share should be in line with market expectations, which it quoted at 200.5p for 2026 and 224.9p for 2027. That implies a heavily second-half-weighted year. The company said revenue would be more weighted to the fourth quarter than usual and described the execution risk as largely within its control. It reported early signs that the Chinese tax exemption processes are being resolved, and said the next Geotek expedition is now expected no earlier than 2028, so none is assumed in 2027.
Brad Ormsby will step down as finance chief and director, staying up to twelve months to hand over.
Why it matters
A half in which adjusted earnings fall by roughly three-quarters while borrowing edges up strains the dividend policy, which now costs more than comfortable cover allows. The reassurance rests on a recovery that has yet to be demonstrated.
Risks
The company flagged a possible further US research budget cut for 2027 and a proposed overhaul of science funding, continued offshore wind weakness, uncertainty over Chinese procurement timing, and geopolitical escalation linked to the Iran conflict, which has so far caused only small lost orders. Its going concern assessment says covenants hold even in a severe downside modelled on a repeat of the 2020 13% fall in orders.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...